Growth Metrics

Nu-Med Plus (NUMD) Payables (2012 - 2025)

Nu-Med Plus recorded quarterly Payables of $148203.0 in Q4 2025, little changed quarter-over-quarter from $147847.0 in Q3 2025, and up 3.61% year-over-year from $143040.0 in Q4 2024.

Nu-Med Plus' Payables history runs 14 years deep, the most recent figure standing at $148203.0 for Q4 2025.

  • In Q4 2025, Payables rose 3.61% year-over-year to $148203.0; the TTM figure through Dec 2025 stood at $148203.0 (up 3.61% YoY), while the FY2025 annual figure was $148203.0, up 3.61% from the prior year.
  • Payables came in at $148203.0 for Q4 2025 at Nu-Med Plus, roughly flat from $147847.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $155204.0 in Q2 2025 to a low of $12645.0 in Q1 2021.
  • A 5-year average of $94245.9 and a median of $108208.5 in 2022 frame the typical range for Payables.
  • Across the five-year window, Payables sank 94.86% in 2021 and jumped 286.36% in 2022, its largest moves.
  • Nu-Med Plus' Payables stood at $27744.0 in 2021, then surged by 286.36% to $107192.0 in 2022, then fell by 6.26% to $100478.0 in 2023, then jumped by 42.36% to $143040.0 in 2024, then rose by 3.61% to $148203.0 in 2025.
  • According to Business Quant data, Payables over the past three periods registered $148203.0, $147847.0, and $155204.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.78 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.74 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.42 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 457.70 Mn
10 Nu-Med Plus - - - 148,203.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 148,203.00
Sep 30, 2025 147,847.00
Jun 30, 2025 155,204.00
Mar 31, 2025 142,995.00
Dec 31, 2024 143,040.00
Sep 30, 2024 119,850.00
Jun 30, 2024 109,225.00
Mar 31, 2024 116,457.00
Dec 31, 2023 100,478.00
Sep 30, 2023 106,585.00
Jun 30, 2023 114,239.00
Mar 31, 2023 113,687.00
Dec 31, 2022 107,192.00
Sep 30, 2022 69,378.00
Jun 30, 2022 59,361.00
Mar 31, 2022 46,244.00
Dec 31, 2021 27,744.00
Sep 30, 2021 18,544.00
Jun 30, 2021 26,000.00
Mar 31, 2021 12,645.00
Dec 31, 2020 26,048.00
Sep 30, 2020 250,100.00
Jun 30, 2020 252,211.00
Mar 31, 2020 246,100.00
Dec 31, 2019 269,920.00
Sep 30, 2019 249,032.00
Jun 30, 2019 235,678.00
Mar 31, 2019 236,100.00
Dec 31, 2018 239,882.00
Sep 30, 2018 236,647.00
Jun 30, 2018 236,597.00
Mar 31, 2018 233,732.00
Dec 31, 2017 234,100.00
Sep 30, 2017 311,910.00
Jun 30, 2017 309,910.00
Mar 31, 2017 313,910.00
Dec 31, 2016 320,967.00
Sep 30, 2016 264,390.00
Jun 30, 2016 254,919.00
Mar 31, 2016 247,985.00
Dec 31, 2015 211,767.00
Sep 30, 2015 230,100.00
Jun 30, 2015 231,100.00
Mar 31, 2015 235,897.00
Dec 31, 2014 230,100.00
Sep 30, 2014 230,100.00
Jun 30, 2014 230,350.00
Mar 31, 2014 232,673.00
Dec 31, 2013 199,500.00
Sep 30, 2013 172,009.00
Jun 30, 2013 107,512.00
Mar 31, 2013 111,976.00
Dec 31, 2012 110,587.00